Drug Information

Drug General Information
Drug ID
D0C3XD
Former ID
DNCL002803
Drug Name
BIO-11006
Indication Chronic obstructive pulmonary disease [ICD9: 490-492, 494-496; ICD10:J40-J44, J47] Phase 2 [522275]
Company
BioMarck Pharmaceuticals
Target and Pathway
Target(s) MARCKS protein Target Info Inhibitor [530770]
References
Ref 522275ClinicalTrials.gov (NCT00648245) Effectiveness and Safety of BIO-11006 Inhalation Solution to Treat the Overproduction of Mucus and Inflammation in COPD. U.S. National Institutes of Health.
Ref 530770Inhibition of myristoylated alanine-rich C kinase substrate (MARCKS) protein inhibits ozone-induced airway neutrophilia and inflammation. Exp Lung Res. 2010 Mar;36(2):75-84.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.